Blood Cancer Treatment Put 94% Of Multiple Myeloma Patients Into Remission

A recent clinical trial in China for a new cancer treatment resulted in 94 percent of patients with multiple myeloma going into complete remission. The treatment, called chimeric antigen receptor, or (CAR) T-cell therapy, is a type of immunotherapy procedure that teaches the patient’s own immune system to attack cancerous cells. Though research is still in…

Leave a Reply

Your email address will not be published. Required fields are marked *